Dura, Elan Corporation plc. deal

ELN, DURA and DURA's Dura Delivery Systems Inc. agreed to develop DURA's Dryhaler pulmonary drug delivery system.

ELN (Ireland) receives exclusive rights to develop, manufacture and market to most major markets outside the U.S. eight respiratory compounds for use in the Dryhaler - albuterol, bitolterol, beclomethasone, budesonide, cromolya, flunisolide, ipratropium and triamcinolone. ...